M&A

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment
Morningstar
Wed, 03/26/25 - 10:19 pm
Alcon
Aurion Biotech
cell therapy
M&A
eye diseases
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Mon, 03/24/25 - 11:08 am
Mira Pharmaceuticals
M&A
Skny Pharmaceuticals
obesity
smoking cessation
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sun, 03/23/25 - 11:45 pm
Jazz Pharma
Chimerix
M&A
Sanofi to acquire Dren Bio’s immunology unit
Investing.com
Thu, 03/20/25 - 11:25 am
Sanofi
Dren Bio
immunology
DR-0201
M&A
autoimmune diseases
Paratek broadens portfolio with Optinose buy worth up to $330m
BioSpace
Thu, 03/20/25 - 11:23 am
Paratek
OptiNose
chronic rhinosinusitis
M&A
AstraZeneca makes potential $1B cell therapy play in EsoBiotec buy
BioSpace
Mon, 03/17/25 - 11:24 am
AstraZeneca
EsoBiotec
cell therapy
M&A
Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic
Fierce Biotech
Mon, 03/17/25 - 11:09 am
Otsuka
Taiho Pharmaceutical
M&A
Araris Biotech
Labcorp is buying Bioreference health’s cancer testing business for $192m
MedCity News
Sun, 03/16/25 - 09:52 pm
Medtech
diagnostics
M&A
LabCorp
BioReference Labs
cancer
Mallinckrodt, Endo near $7B merger: report
First Word Pharma
Wed, 03/12/25 - 11:22 pm
Mallinckrodt
Endo
opioid crisis
M&A
India's Zydus Lifesciences to buy 86% stake in French medical devices maker
Yahoo/Reuters
Wed, 03/12/25 - 11:13 am
Zydus
M&A
Amplitude Surgical
Medtech
India
2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M
BioPharma Dive
Tue, 03/11/25 - 11:33 am
2seventy bio
Bluebird Bio
Bristol Myers Squibb
cell therapy
M&A
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Fierce Pharma
Mon, 03/10/25 - 11:15 am
Sun Pharma
Checkpoint Therapeutics
M&A
Unloxcyt
Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Fierce Biotech
Wed, 03/5/25 - 12:03 pm
Jazz Pharma
M&A
Chimerix
dordaviprone
diffuse glioma
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II
MSN/Seeking Alpha
Fri, 02/28/25 - 11:10 am
BridgeBio
BridgeBio Oncology Therapeutics
M&A
Helix
AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration
Pharma Voice
Fri, 02/28/25 - 11:05 am
Recursion Pharmaceuticals
Exscientia
artificial intelligence
M&A
Why Walgreens Boots Alliance Rose Even on a Bad Day for the Markets
Motley Fool
Thu, 02/27/25 - 09:20 pm
Walgreens Boots Alliance
pharmacies
M&A
Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs
Fierce Pharma
Wed, 02/26/25 - 11:27 am
Jazz Pharma
M&A
earnings
Epidiolex
Quest to buy Fresenius Medical Care kidney testing assets
Medtech Dive
Wed, 02/26/25 - 11:09 am
Quest Diagnostics
M&A
Fresenius Medical Care
diagnostics
kidney disease
Medtech
Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B
Medtech Dive
Wed, 02/26/25 - 11:07 am
Thermo Fisher
M&A
Solventum
filtration
drug manufacturing
Medtech
AstraZeneca builds in China as Cosette buys Mayne
Pharmaphorum
Fri, 02/21/25 - 11:09 am
M&A
Cosette
Mayne Pharma
AstraZeneca
China
FibroGen

Pages